ANL 10.70 Increased By ▲ 0.19 (1.81%)
ASC 9.75 Increased By ▲ 0.42 (4.5%)
ASL 10.54 Increased By ▲ 0.03 (0.29%)
AVN 69.14 Increased By ▲ 0.74 (1.08%)
BOP 5.94 Increased By ▲ 0.02 (0.34%)
CNERGY 5.35 Increased By ▲ 0.15 (2.88%)
FFL 6.49 Increased By ▲ 0.08 (1.25%)
FNEL 6.15 Increased By ▲ 0.05 (0.82%)
GGGL 11.20 Increased By ▲ 0.15 (1.36%)
GGL 15.25 Increased By ▲ 0.08 (0.53%)
GTECH 9.38 Increased By ▲ 0.38 (4.22%)
HUMNL 6.45 Increased By ▲ 0.10 (1.57%)
KEL 2.55 No Change ▼ 0.00 (0%)
KOSM 2.90 Increased By ▲ 0.01 (0.35%)
MLCF 27.86 Decreased By ▼ -0.79 (-2.76%)
PACE 2.95 Increased By ▲ 0.05 (1.72%)
PIBTL 6.09 Increased By ▲ 0.09 (1.5%)
PRL 15.30 Increased By ▲ 0.55 (3.73%)
PTC 6.86 Decreased By ▼ -0.07 (-1.01%)
SILK 1.04 Increased By ▲ 0.03 (2.97%)
SNGP 26.40 Decreased By ▼ -0.20 (-0.75%)
TELE 10.28 Increased By ▲ 0.10 (0.98%)
TPL 8.90 Decreased By ▼ -0.10 (-1.11%)
TPLP 15.89 Increased By ▲ 0.13 (0.82%)
TREET 30.60 Increased By ▲ 0.55 (1.83%)
TRG 75.20 Increased By ▲ 1.49 (2.02%)
UNITY 21.75 Increased By ▲ 0.18 (0.83%)
WAVES 12.52 Increased By ▲ 0.22 (1.79%)
WTL 1.48 Increased By ▲ 0.03 (2.07%)
YOUW 4.87 Decreased By ▼ -0.04 (-0.81%)
BR100 4,235 Increased By 15.3 (0.36%)
BR30 14,533 Increased By 156.4 (1.09%)
KSE100 42,773 Increased By 105.9 (0.25%)
KSE30 16,265 Increased By 52.5 (0.32%)
World

EU concludes preliminary talks to buy up to 200mn doses of Novavax COVID vaccine

  • The possible deal with Novavax would be the seventh sealed by the EU with vaccine makers for the supply of COVID-19 shots.
17 Dec, 2020

BRUSSELS: The European Union has concluded preliminary talks with U.S. firm Novavax to secure up to 200 million doses of its COVID-19 vaccine candidate, a Commission spokesman said on Thursday.

"The envisaged contract foresees the possibility for member states to buy 100 million doses with the option of buying another 100 million doses," the spokesman said.

Reuters reported in September that the EU was in talks to secure the Novavax vaccine.

The conclusion of preliminary talks opens the way for negotiating a contract with Novavax, in a process that could take weeks or months.

The possible deal with Novavax would be the seventh sealed by the EU with vaccine makers for the supply of COVID-19 shots.

It already has agreements with AstraZeneca, Johnson & Johnson, Pfizer-BioNTech, CureVac, Moderna and Sanofi-GSK for a total of nearly 2 billion doses.

Comments

Comments are closed.